Evidence map›Paper›PMID 27502851›Full record

ArticleAmerican heart journal2016

A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study.

Ingrid E Christophersen, Xiaoyan Yin, Martin G Larson, Steven A Lubitz, Jared W Magnani, David D McManus, Patrick T Ellinor, Emelia J Benjamin

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in American heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05442203 (Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease), which is not on this map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05442203 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

TypeinterventionalSponsorTempus AIRan2022 to 2025Enrolled1,000ConditionsAtrial Fibrillation, Structural Heart DiseaseArmsZio Patch Monitor, Echocardiogram
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. A new score with superior stroke risk prediction in atrial fibrillation: entropy-based information gain approaches in a large nationwide cohort.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Review
  10. Observational
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Ingrid E ChristophersenCardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Program in Medical and Population Genetics, The Broad Institute of Harvard and MIT, Cambridge, MA; Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Norway.
Xiaoyan YinNHLBI and Boston University's Framingham Heart Study, Framingham, MA; Department of Biostatistics, Boston University School of Public Health, Boston, MA.
Martin G LarsonNHLBI and Boston University's Framingham Heart Study, Framingham, MA; Department of Biostatistics, Boston University School of Public Health, Boston, MA; Mathematics and Statistics Department, Boston University, Boston, MA.
Steven A LubitzCardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Program in Medical and Population Genetics, The Broad Institute of Harvard and MIT, Cambridge, MA; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA.
Jared W MagnaniNHLBI and Boston University's Framingham Heart Study, Framingham, MA; Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA.
David D McManusDepartment of Medicine, Cardiovascular Medicine Division, University of Massachusetts Medical School, Worcester, MA.
Patrick T EllinorCardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Program in Medical and Population Genetics, The Broad Institute of Harvard and MIT, Cambridge, MA; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA.
Emelia J BenjaminNHLBI and Boston University's Framingham Heart Study, Framingham, MA; Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA; Boston University School of Public Health, Boston, MA. Electronic address: emelia@bu.edu.
Framingham Heart Study · USMassachusetts General Hospital · USBoston University · USBroad Institute · USUniversity of Massachusetts Chan Medical School · US

Funding

IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
AFGen Consortium: Atrial Fibrillation Genomics to Functional AnalysesR01HL128914 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2015 to 2018
$3.1M
Mentoring in Arrhythmia ResearchK24HL105780 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ELLINOR, PATRICK THOMAS · 2011 to 2020
$1.2M
Risk prediction of atrial fibrillation: clinical, biological and genetic markersRC1HL101056 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALONSO, ALVARO, BENJAMIN, EMELIA J. · 2009 to 2010
$967k
Atrial Fibrillation: Bridging genetic discovery and clinical associationsK23HL114724 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LUBITZ, STEVEN A · 2013 to 2017
$893k
Doris Duke Charitable Foundation 2014105Doris Duke Charitable Foundation 2015084NHLBI NIH HHS K23 HL114724NHLBI NIH HHS K24 HL105780NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL128914NHLBI NIH HHS RC1 HL101056
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) affects more than 33 million individuals worldwide and increases risks of stroke, heart failure, and death. The CHARGE-AF risk score was developed to predict incident AF in three American cohorts and it was validated in two European cohorts. The CHA2DS2-VASc risk score was derived to predict risk of stroke, peripheral embolism, and pulmonary embolism in individuals with AF, but it has been increasingly used for AF risk prediction. We compared CHARGE-AF risk score versus CHA2DS2-VASc risk score for incident AF risk in a community-based cohort. METHODS AND

resultsWe studied Framingham Heart Study participants aged 46 to 94 years without prevalent AF and with complete covariates. We predicted AF risk using Fine-Gray proportional sub-distribution hazards regression. We used the Wald χ(2) statistic for model fit, C-statistic for discrimination, and Hosmer-Lemeshow (HL) χ(2) statistic for calibration. We included 9722 observations (mean age 63.9 ± 10.6 years, 56% women) from 4548 unique individuals: 752 (16.5%) developed incident AF and 793 (17.4%) died. The mean CHARGE-AF score was 12.0 ± 1.2 and the sub-distribution hazard ratio (sHR) for AF per unit increment was 2.15 (95% CI, 99-131%; P < .0001). The mean CHA2DS2-VASc score was 2.0 ± 1.5 and the sHR for AF per unit increment was 1.43 (95% CI, 37%-51%; P < .0001). The CHARGE-AF model had better fit than CHA2DS2-VASc (Wald χ(2) = 403 vs 209, both with 1 df), improved discrimination (C-statistic = 0.75, 95% CI, 0.73-0.76 vs C-statistic = 0.71, 95% CI, 0.69-0.73), and better calibration (HL χ(2) = 5.6, P = .69 vs HL χ(2) = 28.5, P < .0001).

conclusionThe CHARGE-AF risk score performed better than the CHA2DS2-VASc risk score at predicting AF in a community-based cohort.

Indexed as

AgedAged, 80 and overAtrial FibrillationCohort StudiesFemaleHumansIncidenceMaleMiddle AgedProportional Hazards ModelsRisk Assessment

Identifiers

PMID27502851
PMCPMC5344697
OpenAlexW2395855281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.